IP Library Granted Patent US 8,420,683
Granted Patent B2
US 8,420,683 · App. 12/601,304 · Granted Apr 16, 2013

5 substituted hydantoins

Inventors: Georgios Sarakinos (Munich, DE); Wilhelmus Hubertus Joseph Boesten (Sittard, NL); Dennis Heemskerk (Schinveld, NL); Ben De Lange (Munstergeleen, NL)
Assignee: DSM Sinochem Pharmaceuticals Netherlands B.V.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,420,683
App. No.
12/601,304
Granted
Apr 16, 2013
Kind
B2
Abstract

The present invention relates to 5-substituted hydantoins, a process for the preparation of 5-substituted hydantoins and the use of 5-substituted hydantoins in the preparation of enantiomerically enriched α-amino acids. Furthermore, the present invention relates to the preparation of pharmaceutically active products such as perindopril and ramipril using the novel 5-substituted hydantoins.

Claims (32)

1. A compound of formula [1]

wherein R 1 is —Z—R 11 with Z is O or S or S(O) or S(O) 2 and R 11 is —C(O)R 111 or —S(O)R 111 or —S(O) 2 R 111 or

wherein R 1 is

and wherein

p has the value 1, 2, 3, 4, 5 or 6 and wherein R 4 and R 5 are independently chosen from the list consisting of —CH 3 , —CH 2 CH 3 , —CH 2 CH 2 CH 3 , —C 6 H 6 , lower alkyl, aryl or wherein R 4 and R 5 are connected to each other to form a ring chosen from the list consisting of —CH 2 CH 2 —, —CH 2 CH 2 CH 2 —, —CH 2 CH 2 CH 2 CH 2 —, —CH 2 CH 2 CH 2 CH 2 CH 2 — and —CH 2 ACH 2 — wherein A is —(CH 2 ) q O—, —(CH 2 ) q S—, —(CH 2 ) q S(O)—, —(CH 2 ) q S(O) 2 — with q is 0, 1, 2, 3 or 4; and

R 2 is —H or —C(O)R 22 or —S(O)R 22 or —S(O) 2 R 22 ; and

R 3 is —H or —C(O)R 33 or —S(O)R 33 or —S(O) 2 R 33 ; and wherein

R 111 , R 22 and R 33 are independently chosen from the list consisting of —H, —CH 3 , —CH 2 X, —CHX 2 , —CX 3 , —C 6 H 6 , —C 6 H 5 X, —C 6 H 4 X 2 lower alkyl and aryl, wherein X represents Br, CH 3 , C 2 H 5 , Cl, F or I, with the proviso that R 2 and R 3 are not —H when Z is S and R 11 is —C(O)CH 3 ; and wherein

R 7 is chosen from the list consisting of —CH 3 , —CH 2 CH 3 , —CH 2 CH 2 CH 3 , —C 6 H 6 , lower alkyl, aryl and substituted derivatives thereof.

2. Compound according to claim 1 wherein R 1 is —Z—R 11 with Z is O or S or S(O) or S(O) 2 and R 11 is —C(O)R 111 or —S(O)R 111 or —S(O) 2 R 111 .

3. Compound according to claim 2 wherein R 1 is —Z—R 11 and Z is O and R 11 is —C(O)H or —C(O)CH 3 and R 2 and R 3 are both —H or both the same as R 11 .

4. Compound according to claim 2 wherein R 1 is —Z—R 11 and Z is S and R 11 , R 2 and R 3 are —C(O)CH 3 .

5. Method for the preparation of a compound according to claim 2 comprising contacting a compound of formula [2]

wherein Z is O or S

(a) with a compound of formula R 111 C(O)Y

wherein R 111 is chosen from the list consisting of —H, —CH 3 , —CH 2 X, —CHX 2 , —CX 3 , —C 6 H 6 , —C 6 H 5 X, —C 6 H 4 X 2 lower alkyl and aryl,

wherein X represents Br, CH 3 , C 2 H 5 , Cl, F or I and Y represents Br, Cl, F, I, OH or OC(O)R 111 , or

(b) with a compound of formula R 111 S(O) n Y

wherein n is 1 or 2,

wherein R 111 is chosen from the list consisting of —H, —CH 3 , —CH 2 X, —CHX 2 , —CX 3 , —C 6 H 6 , —C 6 H 5 X, —C 6 H 4 X 2 lower alkyl and aryl,

wherein X represents Br, CH 3 , C 2 H 5 , Cl, F or I and Y represents Br, Cl, F, I, OH or OS(O) n R 111 .

6. Method according to claim 5 further comprising contacting the product obtained in (a) or (b) with an enamine of the general formula [3] or a ketoester of general formula [3a]

wherein p has the value 1, 2, 3, 4, 5 or 6 and wherein R 4 and R 5 are independently chosen from the list consisting of —CH 3 , —CH 2 CH 3 , —CH 2 CH 2 CH 3 , —C 6 H 6 , lower alkyl, aryl or wherein R 4 and R 5 are connected to each other to form a ring chosen from the list consisting of —CH 2 CH 2 —, —CH 2 CH 2 CH 2 —, —CH 2 CH 2 CH 2 CH 2 —, —CH 2 CH 2 CH 2 CH 2 CH 2 — and —CH 2 ACH 2 — wherein A is —(CH 2 ) q O—, —(CH 2 ) q S—, —(CH 2 ) q S(O)—, —(CH 2 ) q S(O) 2 — with q is 0, 1, 2, 3 or 4, and R 7 is chosen from the list consisting of —CH 3 , —CH 2 CH 3 , —CH 2 CH 2 CH 3 , —C 6 H 6 , lower alkyl, aryl and substituted derivatives thereof, followed by hydrolysis to give a compound of the general formula [4]

wherein p has the meaning as defined above.

7. Method according to claim 6 further comprising contacting said compound of general formula [4] with a hydantoinase, a carbamoylase and a hydantoin racemase to give a compound of the general formula [5]

wherein p has the value 1, 2, 3, 4, 5 or 6.

8. Method according to claim 7 further comprising subjecting said compound of general formula [5] to hydrogenation to give a compound of the general formula [6]

wherein p has the value 1, 2, 3, 4, 5 or 6.

9. Method according to claim 8 further comprising contacting said compound of general formula [6] with a compound of general formula [7] or a compound of general formula [8]

wherein R 6 is —CH 3 or phenyl, to give a compound of the general formula [9]

wherein p has the value 1, 2, 3, 4, 5 or 6.

10. Method according to claim 9 wherein R 6 is —CH 3 and p has the value 4 or wherein R 6 is phenyl and p has the value 3.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2012
From: DSM IP ASSETS B.V.
To: DSM SINOCHEM PHARMACEUTICALS NETHERLANDS B.V.
Reel/Frame 028638/0486 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2010
From: SARAKINOS, GEORGIOS; BOESTEN, WILHELMUS HUBERTUS JOSEPH; HEEMSKERK, DENNIS; DE LANGE, BEN
To: DSM IP ASSETS B.V.
Reel/Frame 023837/0588 →
Priority Claims (1)
EP 07109684 · Jun 6, 2007 · regional
Continuity (1)
Related Publication 20100174092A1 · Jul 8, 2010